GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jiangsu Recbio Technology Co Ltd (FRA:G93) » Definitions » EPS (Basic)

Jiangsu Recbio Technology Co (FRA:G93) EPS (Basic) : €-0.07 (TTM As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Jiangsu Recbio Technology Co EPS (Basic)?

Jiangsu Recbio Technology Co's basic earnings per share (Basic EPS) for the six months ended in Jun. 2024 was €-0.07. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Jun. 2024 was €-0.07.

Jiangsu Recbio Technology Co's EPS (Diluted) for the six months ended in Jun. 2024 was €-0.07. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was €-0.07.

Jiangsu Recbio Technology Co's EPS without NRI for the six months ended in Jun. 2024 was €-0.06. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2024 was -0.06.

During the past 3 years, the average EPS without NRI Growth Rate was -41.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 5 years, Jiangsu Recbio Technology Co's highest 3-Year average EPS without NRI Growth Rate was -41.00% per year. The lowest was -70.20% per year. And the median was -55.60% per year.


Jiangsu Recbio Technology Co EPS (Basic) Historical Data

The historical data trend for Jiangsu Recbio Technology Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Recbio Technology Co EPS (Basic) Chart

Jiangsu Recbio Technology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EPS (Basic)
-0.04 -0.05 -0.20 -0.21 -0.15

Jiangsu Recbio Technology Co Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EPS (Basic) Get a 7-Day Free Trial Premium Member Only - - - - -0.07

Jiangsu Recbio Technology Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Jiangsu Recbio Technology Co's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-73.455-0)/480.944
=-0.15

Jiangsu Recbio Technology Co's Basic EPS for the quarter that ended in Jun. 2024 is calculated as

Basic EPS (Q: Jun. 2024 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-31.903-0)/478.907
=-0.07

EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jiangsu Recbio Technology Co  (FRA:G93) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Jiangsu Recbio Technology Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Jiangsu Recbio Technology Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.


Jiangsu Recbio Technology Co Business Description

Traded in Other Exchanges
Address
No. 888 Yaocheng Avenue, Medical High-tech District, Jiangsu Province, Taizhou, CHN
Jiangsu Recbio Technology Co Ltd is a vaccine company dedicated to the development and commercialization of safer and more effective vaccines to address the far-unmet public needs. Hygiene needs. The company focuses on the R&D of HPV vaccine candidates. The company's vaccine portfolio currently consists of 12 vaccines, including three strategic products, namely REC603, a recombinant HPV 9-valent vaccine under phase III clinical trial.

Jiangsu Recbio Technology Co Headlines

No Headlines